35 results on '"Poves, Carmen"'
Search Results
2. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer
3. In-Depth Proteomic Analysis of Paraffin-Embedded Tissue Samples from Colorectal Cancer Patients Revealed TXNDC17 and SLC8A1 as Key Proteins Associated with the Disease
4. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis
5. Clinical and Pathological Characterization of Lynch-Like Syndrome
6. Mo1151 COLORECTAL ADENOMA PREVALENCE AND INCIDENCE IN LYNCH SYNDROME BY GENE
7. p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins
8. 163 - ¿ES NECESARIO EL CRIBADO DE CÁNCER GÁSTRICO EN EL SÍNDROME DE LYNCH?
9. INCIDENCIA, TASA DE DETECCIÓN DE ADENOMAS Y FACTORES DE RIESGO DE CRC SEGÚN EL GEN AFECTO EN EL SÍNDROME DE LYNCH
10. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening
11. Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing
12. Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
13. In‐depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer
14. ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer
15. In-depth proteomics characterization of ΔNp73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer.
16. Mo1154 IS GASTRIC CANCER SCREENING NECESSARY IN LYNCH SYNDROME?
17. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
18. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform
19. 598 POST-COLONOSCOPY COLORECTAL CANCER IN LYNCH SYNDROME IS ASSOCIATED WITH QUALITY ISSUES DURING SURVEILLANCE
20. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome
21. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome.
22. 1065 Incidence of Colonic Neoplasia in Patients With Serrated Polyposis Syndrome Who Undergo Endoscopic Surveillance: A Multicenter Study
23. Mo1736 - Identification of Clinical, Genetic and Endoscopic Predictors of Incident Colorectal Cancer in Lynch Syndrome
24. 1071 - Clinical and Molecular Characterization of Lynch-Like Syndrome
25. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study
26. Carcinoid tumor and patent foramen ovale
27. Su1768 - Colorectal Cancer Incidence in Lynch Syndrome Patients: First Report of a Multicenter Nation-Wide Study
28. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals
29. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.
30. Tumor carcinoide y foramen oval permeable
31. CLINICAL AND MOLECULAR CHARACTERIZATION OF LYNCH-LIKE SYNDROME
32. POST-COLONOSCOPY COLORECTAL CANCER IN LYNCH SYNDROME IS ASSOCIATED WITH QUALITY ISSUES DURING SURVEILLANCE
33. IDENTIFICATION OF CLINICAL, GENETIC AND ENDOSCOPIC PREDICTORS OF INCIDENT COLORECTAL CANCER IN LYNCH SYNDROME
34. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome.
35. [Carcinoid tumor and patent foramen ovale].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.